Rothschild & Co Asset Management US’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $6.82M | Buy |
369,648
+154,713
| +72% | +$2.86M | 0.1% | 151 |
|
2022
Q3 | $5.8M | Sell |
214,935
-1,535
| -0.7% | -$41.4K | 0.1% | 159 |
|
2022
Q2 | $2.99M | Sell |
216,470
-5,938
| -3% | -$82.1K | 0.05% | 220 |
|
2022
Q1 | $4.34M | Sell |
222,408
-66,716
| -23% | -$1.3M | 0.06% | 217 |
|
2021
Q4 | $4.72M | Sell |
289,124
-15,148
| -5% | -$247K | 0.06% | 223 |
|
2021
Q3 | $8.48M | Sell |
304,272
-40,759
| -12% | -$1.14M | 0.11% | 193 |
|
2021
Q2 | $10.2M | Sell |
345,031
-38,797
| -10% | -$1.15M | 0.12% | 184 |
|
2021
Q1 | $10.7M | Sell |
383,828
-46,008
| -11% | -$1.29M | 0.13% | 188 |
|
2020
Q4 | $12.2M | Sell |
429,836
-8,485
| -2% | -$240K | 0.16% | 176 |
|
2020
Q3 | $11M | Sell |
438,321
-45,255
| -9% | -$1.14M | 0.2% | 184 |
|
2020
Q2 | $11.8M | Buy |
483,576
+3,209
| +0.7% | +$78.4K | 0.17% | 200 |
|
2020
Q1 | $7.11M | Sell |
480,367
-79,397
| -14% | -$1.18M | 0.11% | 228 |
|
2019
Q4 | $9.09M | Buy |
559,764
+524,707
| +1,497% | +$8.52M | 0.09% | 257 |
|
2019
Q3 | $456K | Buy |
35,057
+7,636
| +28% | +$99.3K | ﹤0.01% | 340 |
|
2019
Q2 | $356K | Sell |
27,421
-291
| -1% | -$3.78K | ﹤0.01% | 344 |
|
2019
Q1 | $437K | Sell |
27,712
-21,729
| -44% | -$343K | ﹤0.01% | 354 |
|
2018
Q4 | $995K | Buy |
49,441
+590
| +1% | +$11.9K | 0.01% | 352 |
|
2018
Q3 | $1.21M | Buy |
48,851
+7,299
| +18% | +$181K | 0.01% | 354 |
|
2018
Q2 | $1.14M | Sell |
41,552
-2,926
| -7% | -$80.3K | 0.01% | 354 |
|
2018
Q1 | $1.37M | Sell |
44,478
-4,823
| -10% | -$149K | 0.02% | 334 |
|
2017
Q4 | $1.76M | Sell |
49,301
-3,707
| -7% | -$133K | 0.02% | 325 |
|
2017
Q3 | $1.46M | Sell |
53,008
-1,158
| -2% | -$31.9K | 0.02% | 317 |
|
2017
Q2 | $1.43M | Sell |
54,166
-2,444
| -4% | -$64.5K | 0.02% | 351 |
|
2017
Q1 | $1.18M | Sell |
56,610
-4,176
| -7% | -$86.8K | 0.01% | 359 |
|
2016
Q4 | $1.26M | Buy |
60,786
+49,978
| +462% | +$1.03M | 0.02% | 373 |
|
2016
Q3 | $175K | Buy |
10,808
+269
| +3% | +$4.36K | ﹤0.01% | 527 |
|
2016
Q2 | $143K | Buy |
+10,539
| New | +$143K | ﹤0.01% | 557 |
|